Skip to main content
. 2012 May 1;3(3):138–150. doi: 10.6004/jadpro.2012.3.3.2

Table 2.

Table 2

Table 2. Pivotal Studies for Treatment of Epidermal Growth Factor Receptor Inhibitor–Associated Rash